Antigen-driven patterns of TCR bias are shared across diverse outcomes of human hepatitis C virus infection JJ Miles, D Thammanichanond, S Moneer, UK Nivarthi, L Kjer-Nielsen, ... The Journal of Immunology 186 (2), 901-912, 2011 | 36 | 2011 |
The processing architectures of whole-object features: A logical-rules approach. S Moneer, T Wang, DR Little Journal of Experimental Psychology: Human Perception and Performance 42 (9 …, 2016 | 29 | 2016 |
Fiber-modified recombinant adenoviral constructs encoding hepatitis C virus proteins induce potent HCV-specific T cell response D Thammanichanond, S Moneer, P Yotnda, C Aitken, L Earnest-Silveira, ... Clinical Immunology 128 (3), 329-339, 2008 | 21 | 2008 |
TCD8 response in diverse outcomes of recurrent exposure to hepatitis C virus M Bharadwaj, D Thammanichanond, CK Aitken, S Moneer, HE Drummer, ... Immunology and cell biology 87 (6), 464-472, 2009 | 13 | 2009 |
Detection of HCV-specific IFN-γ responses in HCV antibody and HCV RNA negative injecting drug users JK Flynn, R Sacks-Davis, P Higgs, C Aitken, S Moneer, V Suppiah, ... Hepatitis Monthly 14 (1), 2014 | 8 | 2014 |
Capacity, categorization, conflict, and resilience XJ Cheng, S Moneer, N Christie, DR Little Systems factorial technology: A theory driven methodology for the …, 2017 | 6 | 2017 |
Categorization, capacity, and resilience XJ Cheng, S Moneer, N Christie, DR Little Systems Factorial Technology, 157-174, 2017 | 4 | 2017 |
EVASION OF LOADING COMPLEX AND PRESENTATION OF NON-CANONICAL PEPTIDES BY HLA-E IMPACTS NKG2-MEDIATED CELLULAR FUNCTION T Kraemer, H Schumacher, T Huyton, S Badrinath, S Moneer, R Blasczyk, ... Tissue Antigens 81 (5), 264-265, 2013 | 1 | 2013 |
Capacity with Distractors XJ Cheng, S Moneer, N Christie, DR Little Systems Factorial Technology: A Theory Driven Methodology for the …, 2017 | | 2017 |
Detection of HCV-Specific IFN-? Responses in HCV Antibody and HCV RNA Negative Injecting Drug Users R Sacks-Davis, P Higgs, C Aitken, S Moneer, V Suppiah, L Tracy, ... Brieflands, 2013 | | 2013 |
813 HEPATITIS C VIRUS-SPECIFIC CELLULAR IMMUNITY DOES NOT PROTECT AGAINST FUTURE HCV INFECTION IN ANTI-HCV NEGATIVE INJECTING DRUG USERS R Sacks-Davis, C Aitken, P Higgs, S Moneer, J Flynn, V Suppiah, L Tracy, ... Journal of Hepatology, S326, 2011 | | 2011 |
Misclassification bias in a cohort of hepatitis C negative injectors P Higgs, C Aitken, S Moneer, M Bharadwaj, L Maher, M Hellard JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 23, A344-A344, 2008 | | 2008 |
633 FIBER-MODIFIED RECOMBINANT ADENOVIRAL CONSTRUCTS ENCODING HEPATITIS C VIRUS PROTEINS ARE POTENT INDUCERS OF HCV-SPECIFIC CYTOTOXIC T CELL RESPONSE M Bharadwaj, D Thammanichanond, P Yotnda, C Aitken, S Moneer, ... Journal of Hepatology 48, S236, 2008 | | 2008 |